v3.26.1
Commitments and Contingencies (Details) - USD ($)
1 Months Ended 12 Months Ended
Oct. 31, 2024
Apr. 01, 2024
Nov. 15, 2023
Aug. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Commitments and Contingencies [Line Items]            
Accrued amount         $ 750,000  
Accrued fees payable         205,000 $ 100,000
Aggregate commitment amount         8,750  
Monthly payments         $ 5,000  
Gross sales revenues percentage         10.00%  
Issuance of common stock shares (in Shares) 2,500          
Common stock market value           100,800
Revenue derived term       10 years    
Research and development expenses         $ 231,593 165,621
Commission expense           0
CFO Agreement [Member]            
Commitments and Contingencies [Line Items]            
Monthly payments to agreement     $ 8,750      
Funds raises         750,000  
Accrued amount         750,000  
Accrued fees payable         98,058 56,375
Aggregate commitment amount         8,750  
Employment Agreement [Member]            
Commitments and Contingencies [Line Items]            
Funds raises         750,000  
Accrued amount         750,000  
Accrued fees payable         161,250 56,250
Aggregate commitment amount         $ 8,750  
Dr. Marvin Hausman [Member]            
Commitments and Contingencies [Line Items]            
Royalty percentage       5.00%    
Nova Mentis Life Science Corp. [Member]            
Commitments and Contingencies [Line Items]            
Royalty payable percentage       2.50%    
Nova Mentis Life Sciences Corp. [Member]            
Commitments and Contingencies [Line Items]            
Royalty payable percentage       2.50%    
Research and development expenses           $ 100,800
Chief Executive Officer [Member] | Employment Agreement [Member]            
Commitments and Contingencies [Line Items]            
Monthly payments to Mr.Reyes   $ 8,750        
Hausman [Member] | Chief Science Officer Agreement [Member]            
Commitments and Contingencies [Line Items]            
Monthly payments   $ 8,750        
Dr. Marvis S. Hausman [Member]            
Commitments and Contingencies [Line Items]            
Monthly payments       $ 245,712    
Common stock market value       $ 100,800    
Dr. Marvis S. Hausman [Member] | Nova Mentis Life Science Corp. [Member]            
Commitments and Contingencies [Line Items]            
Issuance of common stock shares (in Shares)       750,000